文献速递其他结缔组织病

系统性硬化症血管结局随时间改善:一项系统综述与荟萃分析研究

Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该系统综述与荟萃分析纳入55项研究,评估系统性硬化症(SSc)相关数字溃疡、肺动脉高压(PAH)和硬皮病肾危象(SRC)的患病率、死亡率及严重程度随时间的变化。结果显示三种血管病变的汇总患病率基本稳定,PAH 1年死亡率和SRC死亡率显著改善,但PAH 3年及5年死亡率无显著变化;SRC永久透析频率随时间增加。

要点

  • 数字溃疡、PAH和SRC的汇总患病率分别为41.0%、9.5%和4.9%,随时间基本稳定。
  • PAH 1年死亡率(P=0.001)和SRC死亡率(P<0.001)显著改善,PAH 3年(P=0.312)和5年(P=0.686)死亡率无显著变化。
  • SRC永久透析频率(35.4%,P=0.036)随时间增加,总体透析频率(66.7%,P=0.297)无显著变化。

核心结论

  • 尽管存在异质性和疾病稀缺性,SSc各种血管并发症已取得重大改善并带来生存获益,多项替代标志物的改善趋势支持血管管理进展转化为患者重大获益。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed 1950-2019年相关文献,纳入全文文章,提取研究特征并评估偏倚风险/质量,共纳入55项研究。

主要发现

  • 数字溃疡、PAH和SRC的汇总患病率分别为41.0%、9.5%和4.9%,随时间基本稳定。
  • PAH 1年死亡率(P=0.001)和SRC死亡率(P<0.001)显著改善,PAH 3年死亡率(P=0.312)和5年死亡率(P=0.686)无显著变化。
  • 数字溃疡愈合患病率无显著变化(P=0.265)。
  • PAH替代标志物(平均肺动脉压、肺血管阻力、右心房压)呈改善趋势(所有P≈0.1)。
  • SRC总体透析频率为66.7%(P=0.297),永久透析频率为35.4%(P=0.036),随时间增加。

局限性

  • 原文报告存在异质性和疾病稀缺性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Vascular disease in SSc is associated with significant morbidity and mortality. Preliminary data may lead to the suggestion of a modifiable unified-vascular endophenotype. Our aim was to determine whether the prevalence, mortality and severity of SSc-vascular disease have changed over time. METHODS: We performed a systematic review and meta-analysis of the literature in PubMed 1950-2019 related to SSc-digital ulcers (DUs), pulmonary artery hypertension (PAH) and scleroderma renal crisis (SRC). We included full-text articles and extracted study characteristics and assessed risk of bias/quality. We examined the prevalence, mortality and surrogate measures of SSc-associated vascular disease severity. RESULTS: We included 55 studies in our meta-analysis. The pooled prevalence of DUs (41.0%), PAH (9.5%) and SRC (4.9%) remained largely stable over time. There was significant improvement in PAH 1-year (P = 0.001) and SRC mortality (P < 0.001), but not PAH 3-year (P = 0.312) or 5-year (P = 0.686) mortality. The prevalence of DU healing did not significantly change (P = 0.265). There was a trend (all P = ∼0.1) towards improvement in PAH surrogates: mean pulmonary artery pressure, pulmonary vascular resistance and right atrial pressure. For SRC, there was evidence that the overall frequency of dialysis (66.7%, P = 0.297) and permanent dialysis (35.4%, P = 0.036) increased over time. CONCLUSION: Despite the heterogeneity and scarcity of the disease, there have been major improvements obtained in the various vascular complications in SSc leading to benefit in survival. This is supported by a trend towards improvement in several surrogate markers and demonstrates that progress in vascular management translates into major patient benefit.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Hughes M, Zanatta E, Sandler RD, et al. Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study. Rheumatology (Oxford). 2022. PMID: 34791057. doi:10.1093/rheumatology/keab850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。